Neuraptive Therapeutics Inc.
Neuraptive Therapeutics is a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI). Their mission is to enhance the quality and speed of recovery for patients suffering from traumatic injuries or undergoing reconstructive surgeries, utilizing innovative technologies such as NTX-001, a nerve fusion system, and specialized microsurgical instruments.
Neuraptive Therapeutics Inc.
851 Duportail Road, Suite 200, Chesterbrook, PA 19087
What We Do
A novel system for repairing severed peripheral nerves, designed to restore electrical signaling and prevent degeneration of axons distal to injury.
A specialized device for the topical administration of active agents directly on the nerve.
Development of nerve-specific microsurgical instruments to address limitations in current nerve repair products.
Regenerative Medicine
News & Updates
Neuraptive Therapeutics announces FDA clearance of IND application for NTX-001, a novel approach for treating peripheral nerve injuries.
Plans to initiate a Phase 2 clinical study for NTX-001 in the prevention of postoperative facial paralysis.